Enfuvirtide (T20; DP178) is an anti-HIV-1 fusion inhibitor peptide and the first agent of its class active against HIV. It has not been linked to serum aminotransferase elevations or clinically apparent liver injury during therapy.
Usually ships within 24 hours.